Literature DB >> 16338989

Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1.

Erzsébet Lizanecz1, Zsolt Bagi, Eniko T Pásztor, Zoltán Papp, István Edes, Noémi Kedei, Peter M Blumberg, Attila Tóth.   

Abstract

It has been proposed that activation of vanilloid receptor-1 (TRPV1) affects the vasotone of resistance arteries. One of the endogenous activators of TRPV1 is anandamide. The effects of anandamide on TRPV1 responsiveness were tested on isolated, pressurized (80 mm Hg) skeletal muscle (m. gracilis) arterioles (179 +/- 33 microm in diameter). We found that the TRPV1 agonist capsaicin (1 microM) elicited a substantial constriction in isolated arterioles (51 +/- 12%). In contrast, anandamide (0-100 microM) did not affect arteriolar diameter significantly (3 +/- 5%). Isolated vessels were also preincubated with anandamide (30 microM for 20 min). This anandamide pretreatment completely blocked capsaicin-induced arteriolar constriction (response decreased to 1 +/- 0.6%), and this inhibition was reversed by a protein phosphatase-2B inhibitor (cyclosporin-A; 100 nM, 5 min) treatment (constriction, 31 +/- 1%). An exogenous TRPV1-expressing cell line [Chinese hamster ovary (CHO)-TRPV1] was used to specifically evaluate TRPV1-mediated effects of anandamide. The efficacy of anandamide in this system, as determined by 45Ca2+ uptake, was 65 +/- 8% of that of capsaicin. Upon treatment of the cells with cyclosporin-A or the protein kinase C activator phorbol 12-myristate 13-acetate (PMA), anandamide was transformed to a full agonist. Anandamide treatment caused an acute desensitization in these cells as measured by intracellular Ca2+ imaging. Application of cyclosporin-A or PMA reversed this desensitization. Our data suggest that anandamide may cause a complete (albeit phosphorylation-dependent) desensitization of TRPV1 in skeletal muscle arterioles and in CHO-TRPV1 cells, which apparently transforms the ligand-gated TRPV1 into a phosphorylation-gated channel. This property of anandamide may provide a new therapeutic strategy to manipulate TRPV1 activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338989     DOI: 10.1124/mol.105.015644

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  30 in total

Review 1.  Vanilloid and melastatin transient receptor potential channels in vascular smooth muscle.

Authors:  Scott Earley
Journal:  Microcirculation       Date:  2010-05       Impact factor: 2.628

2.  Differential modulation of agonist and antagonist structure activity relations for rat TRPV1 by cyclosporin A and other protein phosphatase inhibitors.

Authors:  Larry V Pearce; Attila Toth; HyungChul Ryu; Dong Wook Kang; Hyun-Kyung Choi; Mi-Kyoung Jin; Jeewoo Lee; Peter M Blumberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-08       Impact factor: 3.000

3.  Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.

Authors:  S Maione; L De Petrocellis; V de Novellis; A Schiano Moriello; S Petrosino; E Palazzo; F Sca Rossi; D F Woodward; V Di Marzo
Journal:  Br J Pharmacol       Date:  2007-02-05       Impact factor: 8.739

4.  Structure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1.

Authors:  Á Czikora; E Lizanecz; P Bakó; I Rutkai; F Ruzsnavszky; J Magyar; R Pórszász; T Kark; A Facskó; Z Papp; I Édes; A Tóth
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 5.  Transient receptor potential channels in the vasculature.

Authors:  Scott Earley; Joseph E Brayden
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 6.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 7.  Calcium signals that determine vascular resistance.

Authors:  Matteo Ottolini; Kwangseok Hong; Swapnil K Sonkusare
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2019-03-18

Review 8.  Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.

Authors:  Henry L Blanton; Jennifer Brelsfoard; Nathan DeTurk; Kevin Pruitt; Madhusudhanan Narasimhan; Daniel J Morgan; Josée Guindon
Journal:  Drugs       Date:  2019-06       Impact factor: 9.546

9.  Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.

Authors:  Andrew J Kwilasz; Rehab A Abdullah; Justin L Poklis; Aron H Lichtman; Sidney S Negus
Journal:  Behav Pharmacol       Date:  2014-04       Impact factor: 2.293

10.  Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat.

Authors:  Attila Tóth; Agnes Czikora; Eniko T Pásztor; Beatrix Dienes; Péter Bai; László Csernoch; Ibolya Rutkai; Viktória Csató; Ivetta S Mányiné; Róbert Pórszász; István Edes; Zoltán Papp; Judit Boczán
Journal:  J Histochem Cytochem       Date:  2013-11-11       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.